Clarinol CLA cuts body fat in obese patients

15 April 2007

USA-based Lipid Nutrition, part of the Loders Croklaan group, says that research published in the British Journal of Nutrition indicates that its product Clarinol CLA, a conjugated linoleic acid-based safflower oil derivative, brings about a reduction in body fat without the need for additional exercise.

The article, which includes data from a placebo-controlled study, shows that subjects using the supplement for a threemonth period lost an average of 2kg of fat from around the waist and leg area compared with those in the control group. Moreover, the weight-loss patterns differed between the genders, with women showing a greater fat reduction around the legs and waist, whereas males in the study tended to lose weight from the stomach and mid-section. The firm added that the overall body weight, hip/waist ratio and body mass index' of patients receiving the supplement were reduced relative to placebo.

According to Marianne O'Shea, director of nutrition for the company, the study confirms that the product can help shape the body. Dr O'shea added that, "with so many overweight and obese people out there for weight loss, it is important to find healthy ways to decrease body fat."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight